Elite Pharmaceuticals Inc
- Close
- Jul 1, 2026
- Market cap
- $387.77M
- 1.08B shares
- Filings
- 1,015
Q2 2027+77.1% FY26 yoy
Q2 2027N/M FY26 yoy
Q2 2027+150.6% FY26 yoy
Q2 2027derived+291.4% FY26 yoy
Q2 2027
Q2 2027+157.2% FY26 yoy
- $387.77M
- 6.4×
- 2.7×
- 3.2×
- 2.25%
- —
Twelve months to Sep 30, 2026 · derived
Price
Jul 1, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | $148,870,119 | reported | |
| FY 2025 | 2025-03-31 | $84,043,929 | reported | |
| FY 2024 | 2024-03-31 | $56,625,128 | reported | |
| FY 2023 | 2023-03-31 | $34,155,114 | reported | |
| FY 2022 | 2022-03-31 | $32,262,117 | reported | |
| FY 2021 | 2021-03-31 | $25,380,749 | reported | |
| FY 2020 | 2020-03-31 | $17,994,639 | reported | |
| FY 2019 | 2019-03-31 | $7,568,508 | reported | |
| FY 2018 | 2018-03-31 | $7,458,711 | reported | |
| FY 2017 | 2017-03-31 | $9,637,715 | reported | |
| FY 2016 | 2016-03-31 | $12,498,332 | reported | |
| FY 2015 | 2015-03-31 | $5,015,246 | reported |
Segments
LineFY2025ShareChange
New Drug Applications$0.00——
ANDA———
NDA———
Total$84.04M
Pharmaceutical preparations
Elite Pharmaceuticals Inc is the 96th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CYRXCryoport, Inc.$176.2M12.4%44.4%$968.4MPHATPhathom Pharmaceuticals, Inc.$175.1M216.9%126.3%$506.9MSNDXSyndax Pharmaceuticals Inc$172.4M627.8%165.6%$1.5BLQDALiquidia Corp$158.3M1,031.2%43.5%$5.2BHRTXHeron Therapeutics, Inc.$154.9M7.4%13.0%$63.1MMGNXMacrogenics Inc$149.5M0.3%49.9%$146.7M
ELTPElite Pharmaceuticals Inc (this company)$148.9M77.1%30.1%$387.8M
KPTIKaryopharm Therapeutics Inc.$146.1M0.6%134.2%$417.3KXNCRXencor Inc$125.6M13.7%73.2%$2.9BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR